Nitric oxide (NO) is synthesized from L-arginine, and in endothelial cells influx of L-arginine is mediated predominantly via Na ϩ -independent cationic amino acid transporters. Constitutive, Ca 2ϩ -calmodulin-sensitive eNOS (endothelial nitric oxide synthase) metabolizes L-arginine to NO and Lcitrulline. eNOS is present in membrane caveolae and the cytosol and requires tetrahydrobiopterin, NADPH, FAD and FMN as additional cofactors for its activity. Supply of L-arginine for NO synthesis appears to be derived from a membrane-associated compartment distinct from the bulk intracellular amino acid pool, e.g. near invaginations of the plasma membrane referred to as 'lipid rafts' or caveolae. Co-localization of eNOS and the cationic amino acid transport system y ϩ in caveolae in part explains the 'arginine paradox', related to the phenomenon that in certain disease states eNOS requires an extracellular supply of L-arginine despite having sufficient intracellular L-arginine concentrations. Vasoactive agonists normally elevate [Ca 2ϩ ] i (intracellular calcium concentration) in endothelial cells, thus stimulating NO production, whereas fluid shear stress, 17␤-oestradiol and insulin cause phosphorylation of the serine/threonine protein kinase Akt/protein kinase B in a phosphoinositide 3-kinase-dependent manner and activation of eNOS at basal [Ca 2ϩ ] i levels. Adenosine causes an acute activation of p42/p44 mitogen-activated protein Biochem. Soc. Symp. 71,[143][144][145][146][147][148][149][150][151][152][153][154][155][156] 
kinase and NO release, with membrane hyperpolarization leading to increased system y ϩ activity in fetal endothelial cells. In addition to acute stimulatory actions of D-glucose and insulin on L-arginine transport and NO synthesis, gestational diabetes, intrauterine growth retardation and pre-eclampsia induce phenotypic changes in the fetal vasculature, resulting in alterations in the Larginine/NO signalling pathway and regulation of [Ca 2ϩ ] i . These alterations may have significant implications for long-term programming of the fetal cardiovascular system.
Role of the L-arginine/NO signalling pathway
Endothelium-derived NO plays an important physiological role in the cardiovascular system, with endothelial dysfunction being involved in the pathogenesis of vascular diseases such as atherosclerosis, diabetes and hypertension [1] . As coronary heart disease is the leading cause of morbidity and mortality in the Western world, elucidation of the signal-transduction mechanisms modulating NO production may provide novel targets for therapeutic intervention.
NO is a labile vasodilator synthesized in endothelial cells from the semiessential cationic amino acid L-arginine and diffuses rapidly to underlying smooth muscle cells to activate soluble guanylate cyclase, causing vascular relaxation [2, 3] (Figure 1 ). Three isoforms of NOS (nitric oxide synthase) have been identified: neuronal NOS, eNOS (endothelial NOS) and iNOS (inducible NOS) [4] . The genes encoding these NOS isoforms have a similar genomic structure and all have an oxygenase domain linked to a C-terminal reductase domain via a binding site for Ca 2ϩ -CaM (calmodulin). Ca 2ϩ -CaM-dependent eNOS is expressed constitutively in vascular endothelial cells and other cell types [5] [6] [7] [8] . eNOS can be activated by a variety of stimuli, such as histamine, bradykinin, 17␤-oestradiol, insulin and shear stress in either a Ca 2ϩ -dependent or a Ca 2ϩ -insensitive manner.
The synthesis of NO from L-arginine requires oxygen, NADPH and the co-factors haem, FAD, FMN and BH 4 (tetrahydrobiopterin) [4] . FAD and FMN in the reductase domain of eNOS receive electrons from NADPH which are passed to the haem centre in the oxygenase domain resulting in enhanced enzyme activity. The electron from the NADPH, via FAD and FMN, interacts with not only the haem domain but also BH 4 , catalysing the reaction of oxygen with L-arginine to generate the intermediate hydroxy-L-arginine and subsequently NO and citrulline. BH 4 enhances the coupling of NADPH oxidation to NO production [4] , as well as providing protection against enzyme inactivation [9] . amino acid transporters family; SLC7A5-11) mediate transport of L-arginine and other cationic amino acids [10] , with CAT-1 (system y ϩ ) being the predominant transporter in endothelial cells. CAT proteins, designated CAT-1, CAT-2A, CAT-2B, CAT-3 and CAT-4, have been identified in different cell types [11, 12] . CAT-1, -2A and -2B are glycosylated, suggesting that these carriers are located in the plasma membrane, with CAT-2A and -2B splice variants differing only in a stretch of 42 amino acids [12] . CAT-4 appears to lack cationic amino acid transport activity whereas the specificity of CAT-3 varies in different tissues. Transport via CAT-1 (system y ϩ ) is pH-independent, and sensitive to trans-stimulation and changes in membrane potential induced by vasoactive agonists [12] .
Intracellular concentrations of L-arginine in endothelial cells range from 0.1 mM in cultured cells to approx. 4 mM in freshly isolated cells [13, 14] . Recycling of L-citrulline to L-arginine via argininosuccinate synthase in the presence of aspartate, MgATP and argininosuccinate lyase [15, 16] does not sustain maximal NO production in agonist-stimulated endothelial cells or cytokine-activated smooth muscle cells [17] . Recent evidence suggests that L-arginine is compartmentalized within a pool separate from the intracellular amino acid pool [18, 19] but in close proximity to plasmalemmal caveolae [20] . Caveolae are specialized invaginations of the plasma membrane (50-100 nm diameter) formed as a result of localized accumulation of cholesterol, glycosphinogolipids and structural proteins [21, 22] . Many signalling molecules, e.g. CAT-1, eNOS, Src kinases, Ras, protein kinase C, oestrogen receptors and heterodimeric G-proteins, are localized to membrane caveolae, highlighting the importance of caveolae in the regulation of signal transduction. Co-localization of eNOS and system y ϩ (CAT-1) in caveolae partly accounts for the 'arginine paradox', namely the discrepancy in the sensitivity of eNOS to extracellular L-arginine in cell-free systems (the K m value of NOS for L-arginine is in the low micromolar range) and studies in vivo where the L-arginine supply seems to limit NO synthesis despite adequate levels of intracellular and circulating L-arginine [20] .
Modulation of L-arginine transport by NO
Influx of L-arginine is increased transiently in endothelial cells stimulated with agonists known to release NO (see Figure 2 ) and elevated significantly in cells expressing iNOS [17, 23, 24] . Acute exposure of endothelial cells to NO donors stimulates L-arginine influx, whereas longer treatment (1-4 h) inhibits transport [25] . Inhibition of L-arginine transport by prolonged NO exposure may be due to oxidation of thiol moieties within the transporter protein [26] . As these studies employed NO donors that also generated superoxide anions, it is possible that the transporter protein was modified by O 2 Ϫ . The transient Adenosine
Potential pathways increase in L-arginine transport observed in agonist-stimulated aortic endothelial cells [17] was attributed to the membrane hyperpolarization induced by ATP or bradykinin, similar to the hyperpolarization induced by adenosine (see Figure 2D ).
Calcium-dependent regulation of endothelial NO production
eNOS is classically activated in a Ca 2ϩ -CaM-dependent manner by vasoactive agonists. Basal [Ca 2ϩ ] i (intracellular calcium concentration) is maintained at concentrations ranging between 50 and 100 nM by multiple mechanisms, such as the regulation of Ca 2ϩ entry into the cell via store-and receptor-operated channels, the extrusion of cytoplasmic Ca 2ϩ via plasma membrane Ca 2ϩ -ATPases, the release of Ca 2ϩ from intracellular stores and re-uptake of Ca 2ϩ into stores via sarcoplasmic/endoplasmic reticulum Ca 2ϩ -ATPases [27] . In endothelial cells, bradykinin and histamine activate phospholipase C, which in turn hydrolyses PtdIns(4,5)P 2 , leading to subsequent production of Ins(1,4,5)P 3 and diacylglycerol ( Figure 1 ). Ins(1,4,5)P 3 then acts on Ins(1,4,5)P 3 receptors located on intracellular stores, leading to release of Ca 2ϩ . Emptying of intracellular stores in turn causes the activation of store-operated channels via a calcium-influx factor, resulting in increased Ca 2ϩ influx [28] . The overall increase in cytosolic Ca 2ϩ in response to histamine or bradykinin leads to Ca 2ϩ -CaM binding to eNOS and increased NO production.
eNOS also associates with several intracellular proteins which affect both its subcellular localization and activity. One such protein is caveolin-1, the main protein found in plasmalemmal caveolae [29, 30] . eNOS undergoes posttranslational palmitoylation and myristoylation in order to be targeted to caveolae [31, 32] and, in endothelial cells, association of eNOS with caveolin inhibits enzyme activity [33] . Caveolin-1-deficient mice exhibit a greater relaxation of phenylephrine pre-constricted rings and 3-fold higher basal cGMP levels than wild-type mice [34, 35] , supporting in vitro observations that caveolin-1 acts as a tonic inhibitor of eNOS.
An association of Hsp90 (heat-shock protein 90) with eNOS has also been reported [36, 37] . Hsp90, a highly conserved stress protein present mainly in the cytosol of cells, plays an important role as a chaperone ensuring appropriate folding of proteins and signal transduction [38] . In endothelial cells bradykinin, VEGF (vascular endothelial growth factor) and shear stress promote association of Hsp90 with eNOS, resulting in enhanced NO production [39] . Hsp90 directly activates eNOS by acting as an allosteric modulator causing a conformational change in the enzyme [39] . Gratton et al. [40] have implicated a reciprocal regulation of eNOS by caveolin-1 and Hsp90, with dissociation of eNOS from caveolin-1 by Ca 2ϩ -CaM facilitated by Hsp90. More recently, Fontana et al. [41] demonstrated that VEGF stimulation leads to recruitment of the serine/threonine kinase Akt/PKB (protein kinase B) and eNOS to adjacent regions of Hsp90, enhancing eNOS phosphorylation and activity ( Figure 3A ) [41] .
eNOS possesses consensus sequences for phosphorylation by protein kinase A, protein kinase C, Akt/PKB and AMP-activated protein kinase [42] .
Many studies have shown that phosphorylation of eNOS on Ser-1177 by Akt/ PKB leads to enzyme activation [43] [44] [45] , whereas phosphorylation on Thr-495 inactivates eNOS [46] . Activation of Akt/PKB occurs via stimulation of PI 3-kinase (phosphoinositide 3-kinase) [47] , with lipid products of PI 3-kinase binding with high affinity to Akt/PKB, leading to phosphorylation of Ser-473 and Thr-308 in the regulatory and catalytic domains, respectively [48, 49] . 
Calcium-insensitive regulation of endothelial NO production
Numerous reports have documented Ca 2ϩ -insensitive regulation of eNOS in response to shear stress, 17␤-oestradiol and insulin, where an increase in NO production is not accompanied by increases in cytosolic Ca 2ϩ [44, 45] . The molecular mechanism underlying Ca 2ϩ -insensitive regulation of eNOS implicates the presence of an autoinhibitory element, a 45-amino acid sequence located near the Ca 2ϩ -CaM-binding site of eNOS, which is believed to hold eNOS in a stable inactive conformation [50] . The autoinhibitory domain is rich in positively charged amino acids, and thus phosphorylation of Ser-633 increases the negative charge in the autoinhibitory domain, enabling displacement of the domain at basal [Ca 2ϩ ] i levels [51] .
Shear stress is not the only stimulus to modulate Ca 2ϩ -insensitive eNOS activity, since both 17␤-oestradiol and insulin acutely stimulate NO production in the absence of significant increases in [Ca 2ϩ ] i [37, [52] [53] [54] [55] . 17␤-Oestradiol enhances the association of eNOS with Hsp90, suggesting that Akt/ PKB activation and Hsp90 association are both necessary but independent mechanisms required for full eNOS activity [55] . Takahashi and Mendelsohn [56] recently reported that the Ca 2ϩ -insensitive activation of eNOS by insulin occurs via association of Hsp90, eNOS and Akt/PKB ( Figure 3B) , a model similar to that reported for Ca 2ϩ -dependent VEGF-induced eNOS activation [41] . Moreover, Butt et al. [51] have also reported that activation of protein kinase G and protein kinase A induces serine phosphorylation of eNOS, rendering it calcium-insensitive. In this study, eNOS was found to be phosphorylated on Ser-1177, Ser-633 and Thr-495, allowing for enzyme activation in the absence of Ca 2ϩ -CaM.
Role of p42/p44 MAPK (p42/p44 mitogen-activated protein kinases)
Shear stress-and 17␤-oestradiol-induced NO production can be prevented by tyrosine kinase inhibitors [57] . Activation of the serine/threonine kinase p42/p44 MAPK occurs via the upstream kinase MEK (mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase), of which there are two isoforms (MEK1/2). MEK1/2 is termed a dual-specificity kinase in that it phosphorylates p42/p44 MAPK on both tyrosine and threonine residues in a TEY motif, resulting in activation of the kinase [58] . Classically, activation of the p42/p44 MAPK pathway by mitogens involves regulation of MEK1/2 by another serine/threonine kinase, Raf-1 [59] . 17␤-Oestradiol-induced activation of p42/p44 MAPK in ovine pulmonary artery endothelial cells appears to modulate [Ca 2ϩ ] i , leading to an increase in endothelial NO production [60] , although studies in human umbilical vein endothelial cells have not documented measurable changes in [Ca 2ϩ ] i [61] . Moreover, activation of p42/p44 MAPK by bradykinin in bovine aortic endothelial cells appears to inhibit eNOS activity via phosphorylation [62] , suggesting that the role of p42/p44 MAPK in regulation of eNOS activity may be stimulatory or inhibitory depending on the stimulus and/or cell type.
Recently we reported [63] that acute activation of endothelial A 2a adenosine receptors increases NO release independent of measurable changes in [Ca 2ϩ ] i , pH or cAMP [63] . Stimulation of fetal endothelial cells with adenosine was also associated with a rapid stimulation of L-arginine transport, membrane hyperpolarization and phosphorylation of p42/p44 MAPK (Figure 2) , which was abolished in the presence of L-NAME (N G -nitro-L-arginine methyl ester). Although genistein and PD98059 inhibited adenosine-stimulated L-arginine transport, NO production and p42/p44 MAPK phosphorylation, we found no evidence for activation of eNOS via Akt/PKB. Thus in fetal endothelial cells adenosine stimulates the L-arginine/NO pathway in a Ca 2ϩ -insensitive manner involving p42/p44 MAPK , with release of NO leading to a membrane hyperpolarization and activation of L-arginine transport. Our findings are consistent with a recent report that H 2 O 2 -induced NO production in aortic endothelial cells is only partially attenuated by PD98059 but completely abolished by inhibitors of PI 3-kinase and MEK1/2, implying a role for both Akt/PKB and p42/p44 MAPK [64] . In agreement with our findings, Cai et al. [64] reported that early activation (Ͻ5 min) of p42/p44 MAPK by H 2 O 2 had no effect on eNOS phosphorylation on Ser-1177, whereas PI 3-kinase/Akt appeared to mediate phosphorylation after Ͼ10 min [64] . The mechanisms by which p42/p44 MAPK regulates eNOS remain to be investigated further and may involve direct phosphorylation of the enzyme and/or regulation of associated proteins.
Modulation of the endothelial L-arginine/NO pathway in diabetes and pre-eclampsia
Reactive oxygen species, generated in response to agonist stimulation or under conditions of prolonged oxidative stress in disease, modulate signaltransduction pathways in vascular cells [65] . Diabetes-and hyperglycaemia-induced vascular dysfunction have been attributed to the inactivation of NO by its reaction with O 2
• Ϫ to form peroxynitrite [66] . In addition to effects on lipid peroxidation and nitration of protein tyrosine residues, peroxynitrite has been reported to oxidize BH 4 , leading to uncoupling of eNOS and increased production of O 2
• Ϫ and H 2 O 2 [67] . Studies in human umbilical vein endothelial cells established that hyperglycaemia (25 mM, 24 h) increases the activity of system y ϩ and eNOS [68] . Elevated glucose induced a time-dependent (6-12 h) and concentration-dependent (K 1/2 , approx. 11 mM) activation of L-arginine transport, which was reversed within 6-10 h of restoring physiological glucose levels. The increased basal [Ca 2ϩ ] i levels in human umbilical vein endothelial cells treated with elevated glucose are consistent with the increased NO production and eNOS expression [68] . Glucose-stimulated NO production has also been documented in human aortic and bovine retinal endothelial cells cultured under hyperglycaemic conditions for 5 days [69, 70] . Our findings of glucose-stimulated L-arginine transport and NO production in human umbilical vein endothelial cells were confirmed in bovine retinal endothelial cells, with elevated glucose also shown to increase the formation of nitrotyrosine [70] . Sobrevia and colleagues [71] have recently reported that a 2 min treatment of umbilical vein endothelial cells with elevated glucose causes a concentration-dependent stim-L-Arginine/NO signalling pathway 151 ulation of L-arginine transport and NO production. In this latter study, the rapid stimulation of L-arginine transport was associated with membrane hyperpolarization, activation of PI 3-kinase and p42/p44 MAPK , and increased phosphorylation of eNOS. Endothelial dysfunction in pre-eclampsia, a leading cause of maternal hypertension in pregnancy, fetal growth restriction, premature birth and fetal and maternal mortality, has been attributed to increased oxidative stress associated with lipid peroxides released from the placenta [72] [73] [74] . We recently reported that basal and histamine-stimulated NO production was significantly increased in fetal endothelial cells from women with pre-eclampsia compared with normal and preterm pregnancies (Figure 4) [75] . Elevated NO production in pre-eclamptic cells was not associated with increased protein levels of eNOS (Figure 4, inset) or soluble guanylate cyclase (results not shown), nor due to a Ca 2ϩ -independent activation of eNOS via Akt/PKB-mediated serine phosphorylation [75] . As iNOS is not expressed in pre-eclamptic umbilical vein endothelial cells, it seems unlikely that the inducible NO pathway was activated by raised circulating lipid peroxides. Activation of soluble guanylate cyclase by CO, generated via metabolism of haem by haem oxygenase [76] , also seems an unlikely explanation in view of the recent report that expression of haem oxygenase-2 in placental villous endothelial cells is reduced in preeclampsia [77] . Although we have not investigated whether dietary antioxidants can reduce the increased NO production in fetal endothelial cells from pre-eclamptic pregnancies, it is worth noting that supplementation with antioxidant vitamins C and E markedly reduces the indices of oxidative stress in women at risk of pre-eclampsia [78] .
In summary, one of the most intriguing observations in our studies is that pregnancy-associated diseases such as gestational diabetes, intrauterine growth retardation and pre-eclampsia induce phenotypic changes in the fetal vasculature, affecting the L-arginine/NO signalling pathway and regulation of intracellular Ca 2ϩ [75, 79] . These pregnancy-induced alterations in endothelial cell function may potentially have significant implications for long-term programming of the fetal cardiovascular system [80] .
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